to Content
Header Image

How Reliable is Evidence in Medicine?

-
Erwin-Schrödinger-Saal
Plenary / Debate
english language

Is evidence-based medicine (EBM) more valid than clinical experience? What are the limitations of scientific evidence? How can gaps between clinical research and practice be closed?

Speakers

C.F. Rehnborg Professor in Disease Prevention and Director, Prevention Research Center, Stanford University School of Medicine, Stanford
Scientific Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna Chair

Prof. John IOANNIDIS

C.F. Rehnborg Professor in Disease Prevention and Director, Prevention Research Center, Stanford University School of Medicine, Stanford

 C.F. Rehnborg Chair in Disease Prevention at Stanford University, Stanford
 Professor of Medicine and Director of the Stanford Prevention Research Center, Stanford University School of Medicine, Stanford
1999-2003 Chair, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina
  Doctorate in Biopathology
  Specialisation in Internal Medicine and Infectious Diseases, Harvard University and Tufts University, NIH - National Institutes of Health, Johns Hopkins University School of Medicine and Tufts University School of Medicine, Boston
1990 Study of Medicine, University of Athens
since 1996 Adjunct Faculty, Tufts University School of Medicine, Boston
since 2002 Professor, Tufts University School of Medicine, Boston
  Adjunct Professor of Epidemiology, Harvard School of Public Health, Boston
  Visiting Professor of Epidemiology and Bio Statistics, Imperial College, London
since 2008 Leader, Genetics/Genomics Component of CTSI - Tufts Clinical and Translational Science Institute and CGEM - Center for Genetic Epidemiology and Modeling, Tufts Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston

Dr. Prof. Giulio SUPERTI-FURGA

Scientific Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna

 Studium Molekulare Biologie (Universität Zürich, Genentech Inc. - San Francisco, Research Institut für Molekulare Pathologie - Wien)
 Wissenschaftlicher Mitarbeiter, Europäisches Laboratorium für Molekularbiologie (EMBL), Heidelberg
1995 Teamleiter, Europäisches Laboratorium für Molekularbiologie (EMBL), Heidelberg
1997-2000 Gastprofessur, Molekulare Biologie, Universität Bologna
2000 Mitgründer und Wissenschaftlicher Direktor, Biotech-Firma Cellzome Inc.
 Zu seinen bedeutendsten wissenschaftlichen Errungenschaften zählen die Aufklärung grundlegender Regulationsmechanismen von Tyrosin-Kinasen, die bei menschlichen Krebserkrankungen von Bedeutung sind, sowie die Entdeckung entscheidender Organisationsgrundsätze des Proteoms höherer Organismen. Seine Arbeit hat direkt zu einem systematischen Verständnis von Infektionen durch Krankheitserreger sowie der Wirkmechanismen bestimmter Arzneistoffe beigetragen. Er ist ein Fürsprecher systembiologischer Ansätze in der Medizin und der Arzneimittelforschung und hat sich zum Ziel gesetzt, Grundlagen- und klinische Forschung zu verknüpfen
seit 2005 Wissenschaftlicher Direktor, CeMM; Gastprofessor für Molekulare Pharmakologie, Medizinischen Universität Wien

Health Symposium

show timetable

16.08.2013

13:00 - 13:15OpeningPlenary
13:15 - 14:30Fair Society, Healthy LivesPlenary
15:00 - 16:30How Reliable is Evidence in Medicine?Plenary
17:00 - 18:00Indroduction to the Main Topics of the Working GroupsPlenary

16.08.-19.08.2013

AUVA: Austrian Charta of PreventionPartner

17.08.2013

05:00 - 08:00Sunrise Hike with Peter HabelerSocial
09:30 - 13:00Working Group 01: Creating Knowledge: Which Freedoms Should Clinical Research Have?Breakout
09:30 - 13:00Working Group 02: Sharing Knowledge: Communication in MedicineBreakout
09:30 - 13:00Working Group 03: Applying Knowledge: Who Is to Take Decisions? Who Is to Set Priorities?Breakout
09:30 - 13:00Working Group 04: Implementing Knowledge: What is the Value of Health?Breakout
13:30 - 15:00BILLA: Who Makes the Decision on Health at the Supermarket?Partner
16:00 - 18:30Reception on the HillSocial
20:00 - 21:30Lüder Wohlenberg "Spontaneous Recovery"Plenary
21:30 - 23:00Student Lounge hosted by PHARMIG - Association of the Austrian Pharmaceutical IndustrySocial

18.08.2013

16:30 - 18:00Presentation of the Working Group ResultsPlenary
20:30 - 23:30Reception hosted by PHARMIG - Association of the Austrian Pharmaceutical IndustryPartner

19.08.2013

09:00 - 10:30Putting Evidence into Policy Practice - Learning from the BestPlenary
11:00 - 12:30Responsibility for Setting the Agenda for Health Care PolicyPlenary
12:30 - 12:45Closing RemarksPlenary
16:30 - 20:30FOPI: The Future of the Healthcare Reform 2013 - 2018. Requirements for a Successful ImplementationPartner